Alternate Name	Item#	Length	Source of Standard	Column #
	2600	1000	NPCR	11765-12764

Description
Additional text area for staging information not already entered in other Text fields.

Rationale
Text documentation is an essential component of a complete electronic abstract and is heavily utilized for quality control and special studies. Text is needed to justify coded values and to document supplemental information not transmitted within coded values. High-quality text documentation facilitates consolidation of information from multiple reporting sources at the central registry.

The text field must contain a description that has been entered by the abstractor independently from the code(s). If cancer abstraction software generates text automatically from codes, the text cannot be utilized to check coded values. Information documenting the disease process should be entered manually from the medical record and should not be generated electronically from coded values.

Instructions

• Prioritize entered information in the order of the fields listed below.
• Text automatically generated from coded data is not acceptable.
• NAACCR-approved abbreviations should be utilized (see Appendix G).
• Do not repeat information from other text fields.
• Additional comments can be continued in empty text fields, including Remarks. For text documentation that is continued from one text field to another, use asterisks or other symbols to indicate the connection with preceding text.
• If information is missing from the record, state that it is missing.
• Do not include irrelevant information.
• Do not include information that the registry is not authorized to collect.

Note: For abstracting software that allows unlimited text, NAACCR recommends that the software indicate to the abstractor the portion of the text that will be transmitted to the central registry.

Suggestions for text:

• Date(s) of procedure(s), including clinical procedures, that provided information for assigning stage
• Organs involved by direct extension
• Size of tumor
• Status of margins
• Number and sites of positive lymph nodes
• Site(s) of distant metastasis
• Physician's specialty and comments

	Item name
	RX Date--DX/Stg Proc
	Collaborative Stage variables
	SEER Summary Stage 1977
	SEER Summary Stage 2000
	Regional Nodes Positive
	Regional Nodes Examined
	RX Hosp--Surg Prim Site
	RX Summ--Surg Prim Site
	RX Hosp--Scope Reg LN Sur
	RX Summ--Scope Reg LN Sur
	RX Hosp--Surg Oth Reg/Dis
	RX Summ--Surg Oth Reg/Dis
	Mult Tum Rpt as One Prim
	Laterality

Data Item(s) to be verified/validated using the text entered in this field
After manual entry of the text field, ensure that the text entered both agrees with the coded values and clearly justifies the selected codes in the following fields:

Item name	Item number
RxDate Dx/Stg Proc	1280
Collaborative Stage variables	2800-2930
SEER Summary Stage 1977	760
SEER Summary Stage 2000	759
Regional Nodes Positive	820
Regional Nodes Examined	830
RX Hosp--Surg Prim Site	670
RX Summ--Surg Prim Site	1290
RX Hosp--Scope Reg LN Sur	672
RX Summ--Scope Reg LN Sur	1292
RX Hosp--Surg Oth Rg/Dis	674
RX Summ--Surg Oth Reg/Dis	1294
Mult Tum Rpt as One Prim	444
Lateraltiy	410